[1]中华医学会神经外科学分会.烟雾病和烟雾综合征诊断与治疗中国专家共识(2024版)[J].中华神经外科杂志, 2024, 40(03):220-229.DOI:10.3760/cma.j.cn112050-20231119-00177.
[2]段炼,暴向阳.烟雾病治疗中国专家共识[J].国际脑血管病杂志,2019,27(9):645-650
[3]Ye F, Li J, Wang T, Lan K, Li H, Yin H, Guo T, Zhang X, Yang T, Liang J, Wu X, Li Q, Sheng W. Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease. Front Neurol. 2021 Jan 15;11:608000. doi: 10.3389/fneur.2020.608000. PMID: 33519687; PMCID: PMC7844095.
[4]Seo WK, Kim JY, Choi EH, Kim YS, Chung JW, Saver JL, Bang OY, Kim GM. Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study. J Am Heart Assoc. 2021 Feb;10(5):e017701. doi: 10.1161/JAHA.120.017701. Epub 2021 Feb 22. PMID: 33615836; PMCID: PMC8174237.
[5]Wang QN, Bao XY, Zou ZX, et al. The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: a prospective trial. Neurosurgical Focus. 2021 Sep;51(3):E9. DOI: 10.3171/2021.6.focus21112. PMID: 34469867.
[6]Aihara Y, Kashiwase S, Chiba K, Yamaguchi K, Okada Y, Kimura T, Kawamata T. Aspirin use and platelet aggregation in ischemic onset-type pediatric moyamoya patients with intractable headaches (moya-ache). Childs Nerv Syst. 2021 May;37(5):1649-1657. doi: 10.1007/s00381-020-04991-y. Epub 2021 Jan 6. PMID: 33404716.
[7]杨恒,苏佳斌,倪伟,等. 烟雾病脑血流重建术后癫痫发作的危险因素分析[J]. 中华神经外科杂志,2019,35(7):664-668. DOI:10.3760/cma.j.issn.1001-2346.2019.07.005.
[8]Liao, Y., Xu, F. & Xu, B. How I do it: superficial temporal artery to middle cerebral artery bypass for moyamoya disease. Acta Neurochir 164, 1855-1859 (2022). https://doi.org/10.1007/s00701-022-05255-1
[9]Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor Welfare, Japan; Guideline Committee 2021 of the Japan Stroke Society. 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo). 2022 Apr 15;62(4):165-170. doi: 10.2176/jns-nmc.2021-0382. Epub 2022 Feb 22. PMID: 35197402; PMCID: PMC9093674.
[10]Yu W, Ren C, Du J, Zhao W, Guo W, Ji X. Remote Ischemic Conditioning for Motor Recovery after Acute Ischemic Stroke. Neurologist. 2023 Nov 1;28(6):367-372. doi: 10.1097/NRL.0000000000000498. PMID: 37247412; PMCID: PMC10627541.